Commonwealth Equity Services’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
Other funds holding OTLK
PA
HF
GWM
Commonwealth Equity Services's OTLK Position: Q2 2026 in Review
Commonwealth Equity Services sold out of Outlook Therapeutics (OTLK) in Q2 2026, closing a stake of 470,000 shares — an estimated $96.7K sold.
Commonwealth Equity Services first reported a position in OTLK in Q1 2020 and held it in 16 quarters. The position peaked at $178K in Q4 2025. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.
- Commonwealth Equity Services reported no remaining Outlook Therapeutics position as of Q2 2026 after selling out during the quarter.
- Commonwealth Equity Services sold 470,000 Outlook Therapeutics shares in Q2 2026, an estimated $96.7K.
- Commonwealth Equity Services first reported a position in Outlook Therapeutics in Q1 2020 and held it in 16 quarters.
- Commonwealth Equity Services's Outlook Therapeutics position peaked at $178K in Q4 2025.
- 69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.